Clinical examination has important role (letter) by Benger, Jonathan
Early intervention for first episode psychosis
Secondary care must become more
responsive to primary care
Editor—Shiers and Lester observe that pri-
mary and secondary care must work
together and that the wider involvement of
the community is the key to success.1
However, they eschew a more detailed
appraisal of these important issues in favour
of a finger wagging at general practice.
They base their predication on several
assumptions. Firstly, they assume that general
practitioners neither recognise early psy-
chotic features nor wish for involvement in
managing mental health. Secondly, they
assume that people with psychotic symptoms
want to see psychiatrists or wish to take medi-
cation commonly believed to
have unpleasant side effects.
Finally, they assume that sec-
ondary care is responsive to
the concerns of primary care
workers and patients alike.
Little of the above holds true.
As a result of recent pressure
from the government (and in
many cases, well before this),
primary care is remarkably
responsive to patients’
demands. Most general prac-
titioners are wholly familiar
with mental health problems,
and so the issue is not one of
training, it is about the nego-
tiation between health profes-
sional, patient, family, and secondary care.
The London borough of Tower Hamlets is
home to large numbers of non-English
speakers. A general practitioner who recog-
nises psychotic features has to persuade the
patient and his or her family that a trip to the
local psychiatric hospital is in the patient’s
best interests, in order to involve the commu-
nity mental health team,which will not accept
referrals from general practitioners unless a
diagnosis of psychosis has been made. This is
antediluvian practice, and, although it may be
a local problem, it is essential that community
mental health teams work more closely with
primary and secondary care if early interven-
tion for first episode psychosis is to be a
success. The new government programme
for the expansion of primary care premises is
an ideal opportunity to bring psychiatric
services into the community.
James N Hardy general practitioner principal
Bethnal Green Health Centre, London E2 6LL
james.hardy@nhs.net
Competing interests: None declared.
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Consider increasing staff at primary care
level before complaining
Editor—Much has been written regarding
awareness or the lack of it in mental health
issues, as a major factor in the degree of
general practitioners’ involvement in the
care of their patients with mental health
problems. Although the article by Shiers
and Lester1 rightly identifies the importance
of primary care involvement, professionals
in the secondary and tertiary care settings
should not lose sight of the fact that,
although they deal with dis-
orders confined to a particu-
lar physiological system and
exhort the need to adhere to
national service frameworks
and evidence based consen-
sus guidelines, general prac-
titioners have to deal with the
entirety of the patient’s
health.
The traditional health-
care delivery system follows
an inverted funnel distribu-
tion, with expansion of serv-
ices at secondary and tertiary
levels. To facilitate greater
involvement of primary care
professionals in mental
health, consideration must be given to
increase the skilled manpower at this level
rather than complain of poor engagement
by them. This would have the added benefit
of services being available to patients within
the primary care setting and reduce the
stigma attached to mental illness.
Prem K Kunjukrishnan specialist registrar in old
age psychiatry
pk.kunjukrishnan@ntlworld.com
Lekshmi Premkumar currently unemployed
Dewsbury and District Hospital, Dewsbury WF13 4HS
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Worldwide burden of psychosis is not as
severe as suggested
Editor—I found the editorial by Shiers and
Lester on early intervention in psychosis
insightful and practical.1 However, it con-
tains an important error. The authors say
that worldwide, the burden of psychosis is
exceeded only by quadriplegia and demen-
tia. Although there can be no doubt that
schizophrenia is a disabling condition with
an early onset, it does not cause the degree
of global burden in terms of disability
adjusted life years (DALYs) or years of life
lost though illness as many chronic condi-
tions. Psychosis ranks 22nd in the worldwide
causes of disability (or 12th, if high income
counties are considered alone) according to
the World Health Organization’s 1999 study
into the global burden of disease.2 The com-
parable rates for unipolar major depression
are fourth and second, respectively. The fig-
ures that Shiers and Lester quote are
derived from people’s perception of disease
burden calculated by WHO’s Assessment
Classification and Epidemiology Group.3 In
this study 241 key informants (health
professionals, policy makers, people with
disabilities, and their carers) from 14
countries were asked to rank 17 health con-
ditions from most disabling to least disa-
bling, but not necessarily taking into account
prevalence. The result was by no means
identical to the global burden of disease
study.
Alex J Mitchell consultant in liaison psychiatry
Leicester General Hospital, Leicester LE5 4PW
alex.mitchell@leicspart.nhs.uk
Competing interests: None declared.
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Paediatrics has a role too
Editor—Shiers’s and Lester’s review should
have mentioned the role of acute paediatrics
in picking up young people with psychosis.1
It is not common but occasionally we meet
quite ill but puzzling teenagers who need a
multidisciplinary assessment to tease out
organic, social, and psychiatric factors
before we can work out what precisely is the
matter. This requires a team of social
workers and child and adolescent psychia-
trists working with the paediatric staff, as
recommended in the hospital national serv-
ice framework for children.2
Sebastian Kraemer consultant child and adolescent
psychiatrist
Whittington Hospital, London N19 5NF
sebastian@kraemer-zurne.freeserve.co.uk
Competing interests: None declared.
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Helicobacter pylori and
gastro-oesophageal reflux
disease
Information on underlying pathology is
not given
Editor—We read with interest the article
by Harvey et al on the effects of
Helicobacter pylori infection on heartburn
and gastro-oesophageal reflux.1 However,
as the authors recognise, the mechanism
by which H pylori infection might
affect reflux symptoms is by altering
secretion of gastric acid, due to the
H pylori related antral gastritis which results
in a net increase in acid secretion.2
Nevertheless, a number of recent studies, by
combining old and new diagnostic tools
(such as pH monitoring, bilimetry, and
intraluminal oesophageal impedance),
are providing a new and more detailed
characterisation of the factors contributing
to the so called gastro-oesophageal reflux
disease.3–5
As Harvey et al recognise, their study
has some weaknesses, due to the absence
of direct information on the pathology
underlying the symptoms of the patients,
and one of these is that a subset of the
enrolled patients might have reflux symp-
toms due to the occurrence of non-acid or
non-liquid reflux events. This may possibly
lead to an underestimation of the real role
of H pylori in the pathogenesis of acid-
related heartburn and gastro-oesophageal
acid reflux.
Giovanni Cammarota assistant professor
gcammarota@rm.unicatt.it
Giovanni B Gasbarrini senior lecturer
Unit of Gastroenterology; Catholic University
Hospital, largo A. Gemelli, 8-00168, Rome, Italy
Competing interests: None declared.
1 Harvey RF, Lane JA, Murray LJ, Harvey IM, Donovan JL,
Nair P. Randomised controlled trial of effects of
Helicobacter pylori infection and its eradication on heart-
burn and gastro-oesophageal reflux: Bristol helicobacter
project. BMJ 2004;328:1417-9.
2 El Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie
C, McColl KE. Helicobacter pylori infection and
abnormalities of acid secretion in patients with duodenal
ulcer disease.Gastroenterology 1995;109:681-91.
3 Tack J, Koek G, Demedts I, Sifrim D, Janssens J.
Gastroesophageal reflux disease poorly responsive to
single-dose proton pump inhibitors in patients without
Barrett’s esophagus: acid reflux, bile reflux, or both? Am J
Gastroenterol 2004;99:981-8.
4 Kawamura O, Aslam M, Rittmann T, Hofmann C, Shaker
R. Physical and pH properties of gastroesophagopharyn-
geal refluxate: a 24-hour simultaneous ambulatory imped-
ance and pH monitoring study. Am J Gastroenterol 2004;
99:1000-10.
5 Shay S, Tutian R, Sifrim D, Vela M, Wise J, Balaji N, et al.
Twenty-four hour ambulatory simultaneous impedance
and pH monitoring: a multicenter report of normal values
from 60 healthy volunteers. Am J Gastroenterol 2004;99:
1037-43.
Important data were not presented
Editor—The paper by Harvey at al shows
several inconsistencies.1 The first line con-
tains an error:most patients withHelicobacter
pylori actually have a mild pangastritis with
normal or decreased intragastric acidity; the
antral inflammation stimulates hypergastri-
naemia but is balanced by a relative
suppression of acid secretion by the oxyntic
body, and duodenal ulcer occurs in only
10% of infected patients.2
The authors seem confused as to
whether they are assessing gastro-
oesophageal reflux disease, as claimed, or
occasional symptoms. The prevalence of
symptoms once a month, the authors’
definition, is very high and may not be
pathological. Authorities propose that
heartburn twice a week is a more reasonable
definition of reflux disease.3
If the study was designed to address the
question of H pylori and reflux the structure
is suboptimal. Well validated questionnaires
designed specifically for reflux symptoms
are available.4 Reflux is more severe in
elderly people,4 5 and by excluding people
over 60 Harvey et al may not have studied
those most at risk. The authors used a ques-
tionnaire, but there is no evidence that this
has been validated against reliable measures
of gastro-oesophageal reflux disease such as
endoscopic Los Angeles scoring or ambula-
tory oesophageal pH monitoring. All these
issues are important when comparing this
paper with the others cited that have used
much more objective diagnoses of the
disease.
Harvey et al discuss the pathophysiology
of the infection, but the important data
relating H pylori clearance, as opposed to
intending eradication, to reflux have not
been presented.
Ian L P Beales senior lecturer
Norfolk and Norwich University Hospital NHS
Trust, Norwich NR4 7TJ
ian.beales@uea.ac.uk
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Stigma, shame, and blame
experienced by patients with
lung cancer
Health promotion and support groups
have a role
Editor—The research article by Chapple et
al highlights problems for lung cancer
patients and their experiences of stigma and
shame bring to mind two allied factors.1
Health promotion strategies have
increased with our identification of chronic
conditions as the major health threat. The
role of industrial development in exacerbat-
ing chronic health issues was implicated, and
initially health promotion advocates contex-
tualised illness with environmental, psycho-
logical and socioeconomic factors.2 Unfortu-
nately the “determinants of health” model
was often viewed as damaging to economic
interests and a more “watered down”
individual version was preferred.3
However, many people (especially those
in lower socioeconomic groups) have fewer
experiences of personal agency and greater
difficulty changing unhealthy behaviours.4
Thus individualised health promotion strat-
egies have worked more effectively for
people in higher socioeconomic groups.3
The individualised model of health promo-
tion has created a society that internalises
the connection between choice, behaviour
and health but reacts by “blaming the
victim.” This phenomenon is ubiquitous in
social and psychological literature including
attitudes to illness.5 Consequently patients
experience further isolation, creating
depression or anxiety, which affects quality
of life and possibly increased morbidity.
Support groups have been found to be
valuable to increase quality of life and expe-
riences of patient agency. In this study
participants who attended support groups
discussed their feelings of shame but were
more aware of the partial culpability of
tobacco companies in product promotion.
This “resistance” to the stigmatisation might
also be seen as a resistance to the
individualisation of their illness.
Rory Coughlan assistant professor of health psychology
Trent University, 1600 West Bank Drive,
Peterborough, Ontario, Canada K9J 7B8
rorycoughlan@trentu.ca
Competing interests: None declared.
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Non-smoker status should also be declared
Editor—I write with reference to the article
by Chapple et al on the negative experiences
of patients with lung cancer.1 I remember a
campaign many years ago encouraging doc-
tors to record on a patient’s death certificate
that a smoking related death was due to
smoking.2 Several years ago my father was
diagnosed with lung cancer. He was a
non-smoker and not even a passive smoker.
In the months leading up to his death I
became concerned that in years to come
people seeing his death certificate in the
archives would assume that he died because
of smoking. This upset me.
After his death I asked the doctor
providing the death certificate to state on
the form that my father was a non-smoker.
This was done. I had one hurdle left. I am
pleased to say that the registrar of births and
deaths accepted the death certificate as it
was written along with the comment that my
father was a non-smoker. This helped me
greatly in the days after my father’s death.
If doctors are to be encouraged to
record on a death certificate that a patient
was a smoker then I think it is only fair that
the opposite can be appended as well.
Keith A Walters consultant in accident and emergency
medicine
Norfolk and Norwich University Hospital, Norwich
NR4 7UY
Kawmeadow@aol.com
Competing interests: None declared.
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Internationally agreed strategy
is needed on vaginal birth
after caesarean
Editor—The review by Guise et al concurs
with other studies in showing that vaginal
birth after caesarean section is harmful for
fetus and mother, and repeated elective
caesarean is not completely protective.1
Systematically interrogating the 160 cases of
uterine rupture reported may have not only
identified important predictive factors for
uterine rupture but also highlighted the
heterogeneity in clinical practice that clearly
exists. Such differences in case selection and
trial abandonment between healthcare pro-
viders probably helps to explain the unex-
pected 10 times greater perinatal mortality
found in Scotland2 but not in the mainly US
population based review by Guise et al.
The development of quality evidence
based guidelines3 4 has been hampered by
the absence of prospective clinical trials and
reliance on retrospective observational data.
Their guidance has focused on ensuring that
women are adequately counselled on the
reasons and risks and benefits of accepting
or declining the trial of vaginal birth after
caesarean, but neglected to provide exact
information on how labour should be
conducted—particularly safe selection,
induction and augmentation strategies. This
may expose the guidelines to unfavourable
critical appraisal and medicolegal challenge.
We therefore believe that prospective
data collection through a central coordinat-
ing body and internationally agreed strategy
should be initiated urgently. This body
should have a dual role in reporting
international observational data sets, and
actively researching preventive strategies by
conducting prospective clinical trials. Both
these functions require a radical improve-
ment in local or national data collection,
standardising terminology (as stated by
Guise et al), and willingness to collaborate in
multicentre research.
Rajesh Varma MRC fellow in obstetrics and gynaecology
r.varma@bham.ac.uk
Janesh K Gupta senior lecturer in obstetrics and
gynaecology
j.k.gupta@bham.ac.uk
Birmingham Women’s Hospital, Birmingham B15 2TG
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Interfacing between primary
and secondary care is needed
Editor—Straus et al highlighted the impact
of severe acute respiratory syndrome
(SARS) on professionalism and gave several
examples of strained professional behav-
iour.1 Research in Hong Kong showed
anxiety among general practitioners who,
despite worries, demonstrated willingness to
do their duty as was expected from a highly
professional workforce.2 Altogether 82.3%
of general practitioners in the study wanted
more involvement in the management of
SARS: 74.6% as educators and 68.4% as
gatekeepers.3 However, the primary care sys-
tem in Hong Kong is less well developed
and most general practitioners work in the
private sector, whereas most hospital care is
given in the public sector, with little interfac-
ing and collaboration.4
Primary care is the gatekeeper to hospi-
tal care. The fear and panic caused by SARS
made it difficult for patients with symptoms
to be managed in primary care without a
close working relationship with and support
system from hospitals. If general practition-
ers had direct access to basic diagnostic pro-
cedures and communicated with the hospi-
tal team directly, they would have more
confidence in screening out suspected cases.
They can also be useful health educators to
minimise panic, which would also decrease
unnecessary admission.
Measures must be taken to avoid over-
loading the hospital system and putting
further strain on frontline doctors in a public
health crisis. This would ensure that profes-
sionalism was not eroded.General practition-
ers are useful partners but not fully used. In
facing new public health challenges, govern-
ments should take the SARS crisis opportu-
nity to strengthen the primary care system
and ensure appropriate mechanisms for part-
nership and interfacing with secondary care.5
Albert Lee professor
alee@cuhk.edu.hk
William Wong assistant professor
Samuel Yeung Shan Wong assistant professor
Department of Community and Family Medicine,
Chinese University of Hong Kong, 4th Floor,
School of Public Health, Prince of Wales Hospital,
Shatin, Hong Kong
Kwong Ka Tsang health promotion officer
Centre for Health Education and Health
Promotion, School of Public Health, Chinese
University of Hong Kong
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Molluscum contagiosum is not
always benign
Editor—I welcome the informative clinical
review on common skin infections in children
by Sladden and Johnston.1 However, when a
Molluscum contagiosum arises in eyelid skin
or even at the eyelid margin, it is far from
benign. The lesion causes chronic keratocon-
junctivitis, which can be easily misdiagnosed
and mistreated if the causative lesion is not
identified. Vascular infiltration and scarring
of the peripheral cornea can occur.2 I expect
to see one or two children a year who have
had a miserable few months with a sore, pho-
tophobic and discharging eye before referral
to the eye clinic. Under such circumstances, I
am sure that prompt treatment of the eyelid
lesion is indicated and a short course of topi-
cal steroid drops may be helpful.
Richard M Redmond consultant ophthalmologist
Scarborough Hospital, Scarborough YO12 6QL
richard.redmond@acute.sney.nhs.uk
Competing interests: None declared.
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All drugs can have serious side
effects
Editor—In their review article, Lee et al say
that further evidence is required before
atypical antipsychotics can be endorsed in
the management of behavioural and psy-
chological symptoms of dementia.1 Of the
five randomised trials reviewed, only three
contained information on adverse events,
and only two of these reported on the
number of serious adverse events.
Currently, no atypical antipsychotic is
licensed for the treatment of behavioural
disturbances in dementia. In March 2004,
after analysing data from randomised
placebo controlled clinical trials and finding
approximately three times the risk of
cerebrovascular adverse events in patients
taking risperidone or olanzapine compared
with placebo, the Committee on Safety of
Medicines advised that risperidone or olan-
zapine should not be used for the treatment
of behavioural symptoms of dementia.2
Perhaps this is all the evidence needed,
but perhaps not. Let us not forget that all
drugs can have serious side effects and that
non-pharmacological interventions are
important.
Anna V Richman specialist registrar in old age
psychiatry
Mossley Hill Hospital, Liverpool L18 8BU
emileandanna@tinyworld.co.uk
Competing interests: None declared.
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Association of British
Pharmaceutical Industry’s code
of practice needs to be clarified
Editor—The article by Eaton does not
entirely reflect the requirements of the
Association of the British Pharmaceutical
Industry’s code of practice for the pharma-
ceutical industry (www.pmcpa.org.uk).1 It is
based on an editorial in the review of the
code of practice from May, which reminded
representatives that agreeing to give money
in exchange for appointments with general
practitioners would be a breach of the code.
The Prescription Medicines Code of Prac-
tice Authority (which administers the code)
occasionally receives reports of general
practitioners’ surgeries asking for a fee to
see representatives. In such circumstances
the authority writes to the general practi-
tioners concerned, asking them to bear in
mind the requirements of clause 15.3 of the
code that no fee should be paid or offered
for an interview. The authority was also
aware of a surgery requesting that pharma-
ceutical company representatives paid a fee
for what seemed to be a social event. No
indication was given that there was any edu-
cational content. Representatives can reim-
burse surgeries for appropriate hospitality
at meetings where the prime purpose is
educational. This is specifically referred
to in the supplementary information to
clause 15.3 of the code. Meetings organised
for groups of doctors and other health
professionals that are wholly or mainly of a
social or sporting nature are unacceptable.
The purpose of the article in May’s review
of the code of practice was to remind com-
panies of what is and what is not permitted
under the code, and that unacceptable
requests from health professionals can be
forwarded to the authority for it to write to
the surgeries concerned and ask that
arrangements be changed.
Heather J Simmonds director
Prescription Medicines Code of Practice Authority,
London SW1A 2 DY
hsimmonds@abpi.org.uk
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The Portman Group does not
represent alcohol industry
Editor—I write with reference to Mayor’s
news item on a researcher, Robin Room,
objecting to a representative from the
drinks industry sitting on an alcohol
research body.1 Room should check his facts
before jumping to conclusions. Here are
some facts.
Firstly, the Portman Group is not a trade
association or lobby group. It does not
represent the industry. It has no commercial
purpose. Its role is to promote responsible
drinking by the consumer and responsible
marketing by producers.
Secondly, I was not nominated to the
Alcohol Education and Research Council
(AERC) by the industry or any industry
related body. I was invited to apply by the
Department for Culture, Media and Sport. I
do not occupy one of the three places on the
council that are traditionally reserved
for industry nominees. This was made
abundantly clear in discussions with the
department and with the chairman of the
council.
Thirdly, neither Robin Room nor any-
one else engaged in alcohol research
registered any concern when one of the
industry representatives on the council was
also the chairman of the Portman Group for
two of the years he served on the council.
His concern about the chief executive is
therefore puzzling.
Fourthly, the Portman Group has
co-funded a number of research projects
with the Alcohol Education and Research
Council in the past, at the invitation of the
council, again without any apparent cause
for concern.
Finally, all members of the Alcohol
Education and Research Council are
appointed as individuals and are committed
as trustees to upholding the independence
and integrity of the council. This I fully
intend to do, whatever the source of any
pressure.
Jean Coussins chief executive
Portman Group, London W1G 9DQ
jcoussins@portmangroup.org.uk
Competing interests: None declared.
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Clinical examination has
important role
Editor—Threatened miscarriage is an
excellent topic for your clinical review
series,1 but it seems odd that Sotiriadis et al
should almost entirely overlook the role of
clinical examination, particularly in an
article titled “evaluation and management.”
After a brief comment that thorough physi-
cal examination is essential to differentiate
between genital and extragenital causes, the
review moves directly from history to
sonographic evaluation and maternal serum
markers.
Many women with vaginal bleeding in
early pregnancy present to primary and
emergency services, where many of the
investigations described in this review are
not immediately available. The exact role
and most appropriate type of physical
examination is unclear,2 and would be
worthy of inclusion in an article intended for
generalist readership.
To overlook physical examination as a
key part of patients’ assessment is contrary
to one of the fundamental principles of
medicine: even if the authors think that it
has a small part to play this should be clearly
stated, and the issues discussed.
Jonathan R Benger consultant in emergency medicine
Academic Department of Emergency Care, United
Bristol Healthcare Trust, Bristol, BS2 8HW
Jonathan.Benger@ubht.swest.nhs.uk
Competing interests: None declared.
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